Arteriosclerosis Thrombosis and Vascular Biology · 2012 · 120 citations · 28 references
Life SciencesBiochemistryCellular BiochemistryEnzymologyLipid BiochemistryEnzyme DeficienciesLipid BiosynthesisLipid MetabolismMacrophage BiologyMetabolic Pathway DefectsSphingolipid MetabolismAtherosclerotic ProgressionCeramide ContentCeramide MetabolismMacrophage MetabolismSphingolipid BiosynthesisSphingolipid Metabolism DefectsSphingomyelin BiosynthesisSphingomyelin Metabolism
OBJECTIVE: Sphingomyelin synthase (SMS) catalyzes the conversion of ceramide to sphingomyelin and sits at the crossroads of sphingolipid biosynthesis. SMS has 2 isoforms: SMS1 and SMS2. Although they have the same SMS activity, they are different enzymes with distinguishable subcellular localizations and cell expression patterns. It is conceivable that these differences could yield different consequences, in terms of sphingolipid metabolism and its related atherogenesis. METHODS AND RESULTS: We created Sms1 gene knockout mice and found that Sms1 deficiency significantly decreased plasma, liver, and macrophage sphingomyelin (59%, 45%, and 54%, respectively), but only had a marginal effect on ceramide levels. Surprisingly, we found that Sms1 deficiency dramatically increased glucosylceramide and GM3 levels in plasma, liver, and macrophages (4- to 12-fold), whereas Sms2 deficiency had no such effect. We evaluated the total SMS activity in tissues and found that Sms1 deficiency causes 77% reduction in SMS activity in macrophages, indicating SMS1 is the major SMS in macrophages. Moreover, Sms1-deficient macrophages have a significantly higher glucosylceramide synthase activity. We also found that Sms1 deficiency significantly attenuated toll-like 4 receptor-mediated nuclear factor-κB and mitogen-activated protein kinase activation after lipopolysaccharide treatment. To evaluate atherogenicity, we transplanted Sms1 knockout mouse bone marrow into low-density lipoprotein receptor knockout mice (Sms1(-/-)→Ldlr(-/-)). After 3 months on a western diet, these animals showed a significant decrease of atherosclerotic lesions in the root and the entire aorta (35% and 44%, P<0.01, respectively) and macrophage content in lesions (51%, P<0.05), compared with wild-type→Ldlr(-/-) mice. CONCLUSIONS: Sms1 deficiency decreases sphingomyelin, but dramatically increases the levels of glycosphingolipids. Atherosclerosis in Sms1(-/-)→Ldlr(-/-) mice is significantly decreased.
28
Functional rafts in cell membranes
Kai Simons, Elina Ikonen · Nature · 1997 · 9.7K citations
Molecular Determinants of Crosstalk between Nuclear Receptors and Toll-like Receptors
Sumito Ogawa, Jean Lozach, Christopher Benner et al. · Cell · 2005 · 640 citations · Full text
Identification of a family of animal sphingomyelin synthases
Klazien Huitema, Joep van den Dikkenberg, Jos F. Brouwers et al. · The EMBO Journal · 2003 · 606 citations · Full text
Double-Stranded RNA-Mediated TLR3 Activation Is Enhanced by CD14
Hyun‐Ku Lee, Stefan Dunzendorfer, Katrin Soldau et al. · Immunity · 2006 · 242 citations · Full text